Emcure Pharmaceuticals (NSE:EMCURE) Total Tax Payable: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:EMCURE Emcure Pharmaceuticals Ltd NSE:EMCURE
42 GF Score
Price ₹1,869.40
! 5 Warning Signs
View Full Analysis

What is Emcure Pharmaceuticals Total Tax Payable?

Emcure Pharmaceuticals NSE:EMCURE -0.48% 42 Total Tax Payable is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:EMCURE with a GF Score™ of 42/100. The stock has 5 warning signs investors should review.

Emcure Pharmaceuticals's Total Tax Payable for the quarter that ended in Jun. 2026 was ₹0 Mil.

Emcure Pharmaceuticals's quarterly Total Tax Payable increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹1,430 Mil) but then declined from Mar. 2026 (₹1,430 Mil) to Jun. 2026 (₹0 Mil).

Emcure Pharmaceuticals's annual Total Tax Payable increased from Mar. 2024 (₹534 Mil) to Mar. 2025 (₹1,123 Mil) and increased from Mar. 2025 (₹1,123 Mil) to Mar. 2026 (₹1,430 Mil).

Emcure Pharmaceuticals Total Tax Payable Related Terms

Emcure Pharmaceuticals Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Emcure Pharmaceuticals's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emcure Pharmaceuticals Total Tax Payable Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Tax Payable
Get a 7-Day Free Trial 621.52 487.75 534.45 1,123.04 1,429.96

Emcure Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,070.04 0.00 1,429.96 0.00
NSE:EMCURE
42GF Score
Emcure Pharmaceuticals Ltd NSE:EMCURE
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Emcure Pharmaceuticals Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of ₹0 Mil mean?
Emcure Pharmaceuticals (NSE:EMCURE) has a Total Tax Payable of ₹0 Mil as of Jun. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Emcure Pharmaceuticals and its competitors.
Is Emcure Pharmaceuticals' Total Tax Payable too high?
Emcure Pharmaceuticals' current Total Tax Payable is ₹0 Mil. Overall, Emcure Pharmaceuticals has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Emcure Pharmaceuticals' Total Tax Payable compare to ZTS?
Emcure Pharmaceuticals' Total Tax Payable of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Emcure Pharmaceuticals and its competitors. Emcure Pharmaceuticals's current Total Tax Payable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emcure Pharmaceuticals stock overvalued right now?
Emcure Pharmaceuticals (NSE:EMCURE) has a current Total Tax Payable of ₹0 Mil. The current Total Tax Payable is ₹0 Mil. Emcure Pharmaceuticals' overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Emcure Pharmaceuticals (NSE:EMCURE), the current Total Tax Payable is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emcure Pharmaceuticals Business Description

Other Exchanges 544210:India
Address Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune, MH, IND, 411 057
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics. The company operates in Derma, Women's Health, Cardiovascular, Neurology, Oncology, Vaccines, and Anti-infectives. Geographically, it operates in India, Europe, Canada, Vietnam, Dubai, and Other Countries.
42GF Score

Get the complete analysis for NSE:EMCURE

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,869.40
Price